Nadarajah Sreeharan, MD PhD FRCP FACP - Institute of Pharmaceutical Sciences - Visiting Professor

Nadarajah Sreeharan

MD PhD FRCP FACP

Institute of Pharmaceutical Sciences

Visiting Professor

London | United Kingdom

Main Specialties: Cardiovascular Disease

Additional Specialties: Cardiovascular Medicine

ORCID logohttps://orcid.org/0000-0002-4839-6804


Top Author

Nadarajah Sreeharan, MD PhD FRCP FACP - Institute of Pharmaceutical Sciences - Visiting Professor

Nadarajah Sreeharan

MD PhD FRCP FACP

Introduction

Prof Sreeharan currently holds Visiting Professorships at King’s College, London & University of Jaffna, Sri Lanka and acts as a Consultant to the Biotechnology Industry. He graduated from the University of Colombo in 1970 with 1st class honours and had his initial postgraduate training at the University of Peradeniya obtaining the MD (Colombo) and subsequently completed the MRCP and a PhD in Cardiovascular physiology at the British Heart Foundation Department of Cardiovascular Studies in Leeds, UK. He is a Fellow of the Royal College of Physicians of London. Edinburgh and Glasgow and of the American College of Physicians.

He was formerly the Foundation Professor of Medicine at the University of Jaffna and held Visiting Professorships at the University of Alberta, Canada, University of Surrey, UK and the UITM Medical Faculty in Kuala Lumpur, Malaysia. During his tenure as Senior Vice President & European Medical Director in the Global R&D organisation at GlaxoSmithKline, he chaired an integrated medical department based across the European countries with oversight for the research & development of new medicines across multiple therapeutic areas. He led teams that developed the first non-ergot selective dopamine agonist for Parkinson’s Disease (ropinirole), the first beta blocker for Heart Failure (carvedilol), an insulin sensitizer for Type 2 Diabetes (rosiglitazone), a combination steroid/LABA for COPD (Seretide), an SSRI for depression/anxiety spectrum (paroxetine), a 5 alpha reductase inhibitor for BPH (dutasteride) and a topoisomerase inhibitor for Ovarian and Small cell Lung cancers (topotecan).

As an Officer of the Board of Examiners in Pharmaceutical Medicine at the Royal College of Physicians, an advisor to the National Board of Medical Examiners in the USA and a faculty to the Scholars in Clinical Science Program at the Harvard Medical School, he facilitated the international development of Pharmaceutical Medicine as an accredited medical specialty. Prof Sreeharan has authored several publications and book chapters on atrial receptors, endothelium dependent relaxation factor, drug development, clinical cardiology and tropical medicine.

Primary Affiliation: Institute of Pharmaceutical Sciences - London , United Kingdom

Specialties:

Additional Specialties:

Research Interests:


View Nadarajah Sreeharan’s Resume / CV

Metrics

Number of Publications

22

Publications

Number of Profile Views

75

Profile Views

Number of Article Reads

77

Reads

Number of PubMed Central Citations

183

PubMed Central Citations

Education

Oct 1985
Royal College of Physicians, London, Edinburgh
FRCP
Jan 1976 - Sep 1979
University of Leeds
PhD
Jan 1976 - Oct 1976
Royal College of Physicians
MRCP (UK)
Oct 1971 - Mar 1974
University of Colombo
MD
Oct 1965 - Sep 1970
University of Colombo
MBBS
Faculty of Pharmaceutical Medicine of the Royal College of Physicians
FFPM
Royal College of Physicians
FRCP
Royal College of Physicians, London
FRCP
Americal College of Physicians
FACP

Experience

Jan 2001 - Jan 1994
GlaxoSmithKline Research and Development
Senior Vice President
Jun 1980 - May 1980
University of Jaffna
Professor of Medicine

Top co-authors

L Hsu
L Hsu

University of California

1

Publications

22Publications

77Reads

183PubMed Central Citations

Development of triglyceride-lowering drugs to address residual cardiovascular risk: strategic and clinical considerations.

Eur Heart J Cardiovasc Pharmacother 2018 Oct;4(4):237-242

Institute of Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, James Clerk Maxwell Building, 57 Waterloo Road, London, UK.

View Article
October 2018
24 Reads

Amoebic Liver Abscess and Indigenous Alcoholic Beverages in the Tropics.

J Trop Med 2018 10;2018:6901751. Epub 2018 Jul 10.

Department of Medicine, Faculty of Medicine, University of Jaffna, Jaffna, Sri Lanka.

View Article
July 2018
52 Reads

Persistent impairment of endothelium-dependent relaxation to acetylcholine and progression of atherosclerosis following 6 weeks of cholesterol feeding in the rabbit.

Can J Physiol Pharmacol 1989 Nov;67(11):1454-60

Department of Medicine, University of Alberta, Edmonton, Canada.

View Article
November 1989
1.550 Impact Factor

Evolution of the responses to exercise in left ventricular aneurysms after anterior wall acute myocardial infarction.

Am J Cardiol 1988 Feb;61(4):236-9

Department of Medicine, University of Alberta, Edmonton, Canada.

View Article
February 1988
3.280 Impact Factor

Absence of effect of calcium antagonists on endothelium-dependent relaxation in rabbit aorta.

Br J Pharmacol 1987 May;91(1):155-64

View Article
May 1987
1 Read
5 PubMed Central Citations(source)
4.840 Impact Factor

Endothelium-dependent relaxation and experimental atherosclerosis in the rabbit aorta.

Can J Physiol Pharmacol 1986 Nov;64(11):1451-3

View Article
November 1986
7 PubMed Central Citations(source)
1.550 Impact Factor

Randomised trial of antivenom in snake envenomation with prolonged clotting time.

Authors:
N Sreeharan

Br Med J (Clin Res Ed) 1985 Aug;291(6493):482

View Article
August 1985
1 PubMed Central Citation(source)

Psychiatric illness and the general physician in a developing country.

Authors:
N Sreeharan

Trop Doct 1984 Apr;14(2):55

View Article
April 1984
0.530 Impact Factor

Hypereosinophilic syndrome.

Ceylon Med J 1983 Jun;28(2):93-5

View Article
June 1983

Humoral nature of the urine response to simulation of atrial receptors.

Q J Exp Physiol 1981 Oct;66(4):431-8

View Article
October 1981
2 PubMed Central Citations(source)

Does the renal humoral response to stimulation of atrial receptors include a natriuresis? [proceedings].

J Physiol 1979 Jun;291:43P-44P

View Article
June 1979
1 PubMed Central Citation(source)
5.040 Impact Factor

Top co-authors

L Hsu
L Hsu

University of California

1